http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019168324-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_665a1ccbeb11cc1bcdd3c4d078d4e3f0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-302 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate | 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7c82927c70a27f40117c35d0dc3cb8f |
| publicationDate | 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019168324-A1 |
| titleOfInvention | Composition for preventing and treating hormonal disorder or andropause in males, containing, as active ingredient, combination of compounds comprising flavonoid derivatives and iridoid derivatives, and use thereof |
| abstract | The present invention relates to a composition for preventing and treating hormonal disorders or andropause in males, containing, as an active ingredient, a herbal medicine extract comprising a combination of compounds comprising flavonoid derivatives and iridoid derivatives, and a use thereof. In an experiment for measuring the effects of a combination comprising (a) monotropein, (b) kaempferol 3-glucoside and (c) quercetin 4'-glucoside (spiraeoside) on the weight of the testes by using an in vivo varicocele animal model, the weight of the left testis in a normal group to which a drug had been administered slightly increased over that of a normal group, and the weight of the left testis in a varicocele mouse group to which a drug had been administered significantly increased over that of a varicocele mouse group. In addition, it has been confirmed that a varicocele mouse group to which a drug is administered has blood testosterone and antioxidant activity-related blood SOD and GSH-Px activities that remarkably increased over those of a varicocele mouse group, and thus the present invention can be effectively used in a pharmaceutical composition, a functional health food and a health supplement for the prevention and treatment of hormonal disorders or andropause in males. |
| priorityDate | 2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.